1 research outputs found
Radical Chemistry and Cytotoxicity of Bioreductive 3āSubstituted Quinoxaline Diā<i>N</i>āOxides
The
radical chemistry and cytotoxicity of a series of quinoxaline di-<i>N</i>-oxide (QDO) compounds has been investigated to explore
the mechanism of action of this class of bioreductive drugs. A series
of water-soluble 3-trifluoromethyl (<b>4</b>ā<b>10</b>), 3-phenyl (<b>11</b>ā<b>19</b>), and 3-methyl
(<b>20</b>-<b>21</b>) substituted QDO compounds were designed
to span a range of electron affinities consistent with bioreduction.
The stoichiometry of loss of QDOs by steady-state radiolysis of anaerobic
aqueous formate buffer indicated that one-electron reduction of QDOs
generates radicals able to initiate chain reactions by oxidation of
formate. The 3-trifluoromethyl analogues exhibited long chain reactions
consistent with the release of the HO<sup>ā¢</sup>, as identified
in EPR spin trapping experiments. Several carbon-centered radical
intermediates, produced by anaerobic incubation of the QDO compounds
with N-terminal truncated cytochrome P450 reductase (POR), were characterized
using <i>N</i>-<i>tert</i>-butyl-Ī±-phenylnitrone
(PBN) and 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-<i>N</i>-oxide (DEPMPO) spin
traps and were observed by EPR. Experimental data were well simulated
for the production of strongly oxidizing radicals, capable of H atom
abstraction from methyl groups. The kinetics of formation and decay
of the radicals produced following one-electron reduction of the parent
compounds, both in oxic and anoxic solutions, were determined using
pulse radiolysis. Back oxidation of the initially formed radical anions
by molecular oxygen did not compete effectively with the breakdown
of the radical anions to form oxidizing radicals. The QDO compounds
displayed low hypoxic selectivity when tested against oxic and hypoxic
cancer cell lines <i>in vitro</i>. The results from this
study form a kinetic description and explanation of the low hypoxia-selective
cytotoxicity of QDOs against cancer cells compared to the related
benzotriazine 1,4-dioxide (BTO) class of compounds